Patent details

EP2782602 Title: Nucleotide DIMS0-150 for use in the treatment of chronic active ulcerative colitis

Basic Information

Publication number:
EP2782602
PCT Application Number:
EP2012073501
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127909042
PCT Publication Number:
WO2013076262
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Nucleotide DIMS0-150 for use in the treatment of chronic active ulcerative colitis
French Title of Invention:
Nucleotide DIMS0-150 por son utilisation dans le traitement de la colite ulcéreuse active chronique
German Title of Invention:
Nukleotid DIMS0-150 zur Verwendung bei der Behandlung von chronisch aktiver Colitis ulcerosa
SPC Number:

Dates

Filing date:
23/11/2012
Grant date:
26/06/2019
EP Publication Date:
01/10/2014
PCT Publication Date:
30/05/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/06/2019
EP B1 Publication Date:
26/06/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/11/2024
Expiration date:
23/11/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/06/2019
 
 

Name:
Index Pharmaceuticals AB
Address:
Tomtebodavägen 23a, 171 77 Stockholm, Sweden (SE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
11/09/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
ADMYRE, Charlotte
Address:
Sweden (SE)

2

Name:
VON STEIN, Petra
Address:
Sweden (SE)

3

Name:
ZARGARI, Arezou
Address:
Sweden (SE)

4

Name:
VON STEIN, Oliver
Address:
Sweden (SE)

Priority

1

Priority Number:
11190826
Priority Date:
25/11/2011
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
201261595230 P
Priority Date:
06/02/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 48/00; A61P 37/00;

Publication

European Patent Bulletin

Issue number:
201926
Publication date:
26/06/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
16/10/2023
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
11/09/2019 Power Of Attorney 1
24/09/2019 Outgoing Correspondence 1